| 1 |
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20(6): 864-874.
|
| 2 |
Zanotti-Cavazzoni SL, Hollenberg SM. Cardiac dysfunction in severe sepsis and septic shock[J]. Curr Opin Crit Care, 2009, 15(5): 392-397.
|
| 3 |
Parker MM. Sepsis-Induced Myocardial Dysfunction: Another Piece in the Puzzle[J]. Pediatr Crit Care Med, 2016, 17(5): 457-458.
|
| 4 |
Zang QS, Wolf SE, Minei JP. Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly[J]. Aging Dis, 2014, 5(2): 137-149.
|
| 5 |
Horton JW, Maass DL, Ballard-Croft C. Rho-associated kinase modulates myocardial inflammatory cytokine responses[J]. Shock, 2005, 24(1):53-58.
|
| 6 |
刘勇, 林建东, 肖雄箭, 等. 脓毒症大鼠心脏组织基因表达变化的研究[J].中国危重病急救学, 2009, 2(3): 155-159.
|
| 7 |
Shao Y, Redfors B, Scharin Täng M, et al. Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy[J]. Int J Cardiol, 2013, 168(3): 1943-1950.
|
| 8 |
Court O, Kumar A, Parrillo JE, et al. Clinical review: Myocardial depression in sepsis and septic shock[J]. Crit Care, 2002, 6(6): 500-508.
|
| 9 |
Merx MW, Weber C. Sepsis and the heart[J]. Circulation, 2007, 116(7): 793-802.
|
| 10 |
秦延军, 于悦卿, 闫雁, 等. 艾司洛尔对早期脓毒症大鼠炎症因子及心功能的影响[J]. 中国现代医学杂志, 2014, 24(1): 13-19.
|
| 11 |
Piquereau J, Godin R, Deschênes S, et al. Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction[J]. Autophagy, 2013, 9(11): 1837-1851.
|
| 12 |
Stengl M, Bartak F, Sykora R, et al. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock[J]. Crit Care Med, 2010, 38(2): 579-587.
|
| 13 |
Cohen RI, Wilson D, Liu SF. Nitric oxide modifies the sarcoplasmic reticular calcium release channel in endotoxemia by both guanosine-3′, 5′ (cyclic) phosphate-dependent and independent pathways[J]. Crit Care Med, 2006, 34(1): 173-181.
|
| 14 |
Flynn A, Chokkalingam Mani B, Mather PJ. Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms[J]. Heart Fail Rev, 2010, 15(6): 605-611.
|
| 15 |
Potz BA, Sellke FW, Abid MR. Endothelial ROS and Impaired Myocardial Oxygen Consumption in Sepsis-induced Cardiac Dysfunction[J]. J Intensive Crit Care, 2016, 2(1). pii: 20.
|
| 16 |
Romero-Bermejo FJ, Ruiz-Bailen M, Gil-Cebrian J, et al. Sepsis-induced cardiomyopathy[J]. Curr Cardiol Rev, 2011, 7(3): 163-183.
|
| 17 |
Chacko CJ, Gopal S. Systematic review of use of β-blockers in sepsis[J]. J Anaesthesiol Clin Pharmacol, 2015, 31(4): 460-465.
|
| 18 |
Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial[J]. JAMA, 2013, 310(16): 1683-1691.
|
| 19 |
Schmittinger CA, Dünser MW, Haller M, et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression[J]. Crit Care, 2008, 12(4): R99.
|
| 20 |
Contenti J, Occelli C, Corraze H, et al. Long-Term β-Blocker Therapy Decreases Blood Lactate Concentration in Severely Septic Patients[J]. Crit Care Med, 2015, 43(12): 2616-2622.
|
| 21 |
Maláska J, Slezák M, Muriová K, et al. Myocardial dysfunction in sepsis--diagnostics and therapy[J]. Vnitr Lek, 2010, 56(3): 226-232.
|
| 22 |
Lorigados CB, Soriano FG, Szabo C. Pathomechanisms of myocardial dysfunction in sepsis[J]. Endocr Metab Immune Disord Drug Targets, 2010, 10(3): 274-284.
|
| 23 |
Ibrahim-Zada I, Rhee P, Gomez CT, et al. Inhibition of sepsis-induced inflammatory response by β1-adrenergic antagonists[J]. J Trauma Acute Care Surg, 2014, 76(2): 320-327
|
| 24 |
Kimmoun A, Louis H, Al Kattani N, et al. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock[J]. Crit Care Med, 2015, 43(9): e332-e340.
|
| 25 |
Thum T, Fraccarollo D, Schultheiss M, et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes[J]. Diabetes, 2007, 56(3): 666-674.
|
| 26 |
胡英, 徐蓉, 杨珍珍, 等. 美托洛尔在抗心律失常治疗中的应用优势[J]. 中华临床医师杂志(电子版), 2013, 7 (11): 4950-4952.
|
| 27 |
Cheng J, Niwa R, Kamiya K, et al. Carvedilol blocks the repolarizing K＋ currents and the L-type Ca2＋ current in rabbit ventricular myocytes[J]. Eur J Pharmacol, 1999, 376(1-2): 189-201.
|
| 28 |
冯耀光, 朱德胜, 王元星, 等. 血管紧张素转换酶抑制剂与β-受体阻滞剂对心瓣膜置换术后心脏结构及功能的影响[J]. 中国胸心血管外科临床杂志, 2011, 18(4): 377-379.
|
| 29 |
Pemberton P, Veenith T, Snelson C, et al. Is It Time to Beta Block the Septic Patient? [J]. Biomed Res Int, 2015, 2015: 424308.
|
| 30 |
Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial[J]. JAMA, 2013, 310(16): 1683-1691.
|